Topic
treatment
Logistics The Chemical Blind Spot in Ballast Water Treatment: Unmonitored Bromoform Risks to Ports and Shipping
Ballast water treatment systems that use oxidant-based methods, such as electrochlorination, generate disinfection by-products like bromoform which accumulate in port waters without monitoring. The IMO's approval process uses a hypothetical Model Harbour rather than real port conditions. Global ballast discharge volumes remain poorly measured, while studies show bromoform concentrations in treated water are ten times higher than in industrial effluents, with estimated annual release of 860 tonnes worldwide.
Manufacturing WHO-Led PARTNERS Trial Begins Patient Enrolment for Bundibugyo Virus Disease Treatments
The PARTNERS clinical trial, sponsored by WHO, has opened patient enrolment in the Democratic Republic of the Congo to evaluate antiviral therapies MBP134 and remdesivir for Bundibugyo virus disease (BVD). The trial aims to identify the first effective treatments for BVD, which has affected over 1,400 people in the current outbreak.
Trade Australia's Medical Innovation: A Legacy of Richard Scolyer
Australian doctor Richard Scolyer, known for his groundbreaking work in cancer treatment, has passed away. His innovative approach to glioblastoma has initiated clinical trials in the US, marking a significant advancement in medical research.